Drug Approval Process in Europe - An Outlook


December 22, 2008
51 Pages - SKU: MC2199637
License type:
Countries covered: Europe

This research deals with the drug approval process in Europe by focussing on the various marketing authorisation procedures, price controls and parallel trading. A snapshot of the biosimilars approval process is also provided along with the key strategic recommendations.



More Drug Discovery reports by Frost & Sullivan

Analysis of the Expanding U.S. Market for Gastrointestinal Disorders Prescription Pharmaceuticals by Frost & Sullivan
This research service is focused on the major bowel disorders and evaluates the market for oral and injectable prescription pharmaceuticals for the treatment of inflammatory ...
U.S. qPCR and dPCR Instrumentation Markets by Frost & Sullivan
This research service evaluates the U.S. quantitative polymerase chain reaction (qPCR) and digital PCR (dPCR) instrumentation markets from 2009 to 2016. Though related, they present ...
The United States Rheumatic Diseases Therapeutics Market by Frost & Sullivan
This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The ...
United States Market for Rheumatoid Arthritis Pharmacotherapeutics by Frost & Sullivan
This research service covers the United States rheumatoid arthritis pharmaceuticals market from 2009 to 2017, with 2011 as the base year. The focus of this ...
See all reports like this >>

More Europe Drug Discovery reports

Generic and innovative drugs market in CIS countries 2013. Russia, Ukraine and Kazakhstan by PMR
Keep current with the changing CIS generic and innovative drug segments.Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015.Generic and innovative ...
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Multiple Sclerosis - United Kingdom ...
PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Multiple Sclerosis - Spain Drug Forecast ...
PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2022 SummaryGlobalData has released its new Country report, “PharmaPoint: Multiple Sclerosis - Italy Drug ...
See all reports like this >>

More Europe reports

European SMB Market Watch Update: January–March 2013 by IDC
This IDC Update presents coverage of the European SMB sector in the first quarter of 2013, with a focus on new products and services, initiatives, ...
Painters & Decorators - Scotland (UK) - Industry Report by Plimsoll Publishing Ltd.
Plimsoll Publishing’s UK Painters & Decorators - Scotland Analysis provides a detailed overview of the UK Painters & Decorators - Scotland market and delivers a ...
Tampons Market in Czech Republic to 2016 by Canadean Ltd
SynopsisThe report presents detailed data on consumption trends in the Tampons category in Czech Republic, analyzing consumption volumes and values. It also provides indispensable data ...
D&B Country Report: Portugal by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>